12 Health Care Stocks Moving In Wednesday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included bioAffinity Technologies (up 54.3%), Gelteq (up 41.4%), and Purple Biotech (up 37.27%). Conversely, notable losers were TScan Therapeutics (down 42.7%), CDT Equity (down 35.48%), and Can Fite Biopharma (down 23.71%). The report highlights substantial price movements across various small-cap biotech and health care companies.
Gainers
- bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednesday's regular session. The company's market cap stands at $3.9 million.
- Gelteq (NASDAQ:GELS) shares increased by 41.4% to $0.75. The market value of their outstanding shares is at $5.6 million.
- Purple Biotech (NASDAQ:PPBT) stock moved upwards by 37.27% to $2.28. The company's market cap stands at $1.5 million.
- ENDRA Life Sciences (NASDAQ:NDRA) shares rose 21.06% to $6.38. The market value of their outstanding shares is at $7.9 million.
- OmniAb (NASDAQ:OABI) stock moved upwards by 19.7% to $5.32. The company's market cap stands at $643.6 million.
- Definitive Healthcare (NASDAQ:DH) shares rose 15.81% to $1.04. The market value of their outstanding shares is at $96.3 million.
Losers
- TScan Therapeutics (NASDAQ:TCRX) stock declined by 42.7% to $0.38 during Wednesday's regular session. The company's market cap stands at $45.1 million.
- CDT Equity (NASDAQ:CDT) shares declined by 35.48% to $0.95. The market value of their outstanding shares is at $1.1 million.
- Can Fite Biopharma (AMEX:CANF) shares fell 23.71% to $2.51. The company's market cap stands at $7.0 million.
- Apimeds Pharmaceuticals (AMEX:APUS) shares fell 21.76% to $2.77. The market value of their outstanding shares is at $5.3 million.
- Lakewood-Amedex (NASDAQ:LABT) shares fell 15.95% to $2.32. The market value of their outstanding shares is at $6.5 million.
- BioXcel Therapeutics (NASDAQ:BTAI) shares declined by 15.48% to $0.12. The company's market cap stands at $4.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.